Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles American Journal of Clinical Medicine Research Year : 2013

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease

Narcisse Elenga
  • Function : Correspondent author
  • PersonId : 948268

Connectez-vous pour contacter l'auteur


Patients with sickle cell disease frequently require red blood cell transfusions. However, transfusions can cause delayed hemolytic transfusion reaction (DHTR), a serious and potentially life-threatening complication of alloimmunization that results in hemolysis of transfused as well as patients' own red cells. Although we are beginning to understand some of the pathophysiology and risk factors associated with alloimmunization, optimal management of DHTR in this patient population is still under debate. Here, I will review the clinical features, pathophysiology, laboratory evaluation, current strategies for management and prevention of DHTRs. Given that DHTRs are associated with massive hemolysis, it is recommended that all patients with sickle cell disease receiving transfusions are carefully and systematically monitored after each transfusion.


Fichier principal
Vignette du fichier
ajcmr-1-3-2.pdf (116.04 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-00922212 , version 1 (24-12-2013)



Narcisse Elenga. Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease. American Journal of Clinical Medicine Research, 2013, 1 (3), pp.40-44. ⟨10.12691/ajcmr-1-3-2⟩. ⟨inserm-00922212⟩


307 View
422 Download



Gmail Facebook X LinkedIn More